TimeMon-Sat 9.00 AM - 6.00 PM
IRINOTECAN 100MG INJECTION

IRINOTECAN 100MG INJECTION

100 INR/Unit

Product Details:

  • Salt Composition Irinotecan Hydrochloride Trihydrate 100mg/5ml
  • Indication Metastatic colorectal cancer, small cell lung cancer, other solid tumors
  • Dosage Form Injection
  • Feature Ready-to-use single dose vial, sterile, non-pyrogenic
  • Ingredients
  • Application
  • Ph Level 3.5 to 3.9
  • Click to view more
X

IRINOTECAN 100MG INJECTION Price And Quantity

  • 100 INR/Unit
  • 1000 , , Unit
  • WHO GMP Certified
  • Hospital/Pharmacy supply
  • Do not mix with other drugs in the same infusion
  • Prescription medication
  • As shown in product image (specific brand dependent)
  • 5 ml
  • Single vial
  • Intravenous (IV) use only

IRINOTECAN 100MG INJECTION Product Specifications

  • Injection
  • 3.5 to 3.9
  • Irinotecan Hydrochloride Trihydrate 100mg/5ml
  • Odorless
  • Metastatic colorectal cancer, small cell lung cancer, other solid tumors
  • AS PER INSTRUCTIONS
  • Clear, pale yellow solution
  • Ready-to-use single dose vial, sterile, non-pyrogenic
  • WHO GMP Certified
  • Hospital/Pharmacy supply
  • Do not mix with other drugs in the same infusion
  • Prescription medication
  • As shown in product image (specific brand dependent)
  • 5 ml
  • Single vial
  • Intravenous (IV) use only

IRINOTECAN 100MG INJECTION Trade Information

  • AHEMDABAD, MUNDRA & MUMBAI
  • 10000 , , Unit Per Month
  • 4 Week
  • Yes
  • Free samples available with shipping and taxes paid by the buyer
  • AS PER REQUIREMENT
  • Australia, South America, Eastern Europe, Western Europe, Middle East, Africa, Asia, Central America, North America
  • All India
  • WHO-GMP

Product Description



IRINOTECAN 100MG INJECTION is an acclaimed, must-have chemotherapeutic solution recognized for its exquisite formulation and peerless efficacy in cancer management. This WHO GMP Certified product combines cost-effectiveness with monumental results, formulated as a clear, pale yellow solution in a ready-to-use, sterile, single-dose vial (5 ml). Intended for intravenous use only and supplied strictly via hospitals and pharmacies, it is prescribed for metastatic colorectal cancer, small cell lung cancer, and various solid tumors. The product adheres to stringent safety, sterility, and regulatory standards, making it an essential for oncology care.

Usage & Application Excellence in Oncology

IRINOTECAN 100MG INJECTION is expertly used in hospitals and oncology clinics, especially for chemotherapy applications treating metastatic colorectal cancer, small cell lung cancer, and other solid tumors. Its ready-to-use, sterile vial assures high material quality, while the non-pyrogenic and odorless solution ensures patient safety. This highly specialized product is administered intravenously under medical supervision, making it a trusted choice among healthcare professionals, especially oncologists and clinical pharmacologists.


Domestic Market Reach and Shipping Information

The main domestic market for IRINOTECAN 100MG INJECTION is India, served efficiently from primary FOB ports. Orders are processed promptly, ensuring reliable shipment to hospitals and pharmacies with controlled expenditures. Each unit comes in secure, single-dose vials with detailed packaging to maintain product integrity during transit. Quick order processing and systematic shipping practices guarantee hospitals and clinics receive timely supplies for uninterrupted patient care.


FAQ's of IRINOTECAN 100MG INJECTION:


Q: How is IRINOTECAN 100MG INJECTION administered to patients?

A: IRINOTECAN 100MG INJECTION is administered by intravenous (IV) infusion under strict medical supervision in a hospital or oncology clinic setting.

Q: What precautions should be taken regarding compatibility and mixing with other medicines?

A: This medication should not be mixed with other drugs in the same infusion. Always follow professional guidelines and use as a single, ready-to-use vial.

Q: Where is the product primarily available and supplied?

A: IRINOTECAN 100MG INJECTION is supplied directly to hospitals and pharmacies, and is intended for use by healthcare professionals in India and for export.

Q: What are the main indications for using IRINOTECAN 100MG INJECTION?

A: It is mainly prescribed for the treatment of metastatic colorectal cancer, small cell lung cancer, and other solid tumors.

Q: What are the storage and handling instructions for this injection?

A: Store the vials as per the instructions provided to ensure product stability and efficacy. Protect from light and do not freeze.

Q: What makes this product a cost-effective and peerless choice for healthcare providers?

A: Its acclaimed efficacy, WHO GMP certification, and reliable, ready-to-use sterile presentation make it both economical and monumentally effective in cancer treatment.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'ANTI CANCER MEDICINES' category



Back to top